
Vivek Ramaswamy
Vermögen: 866 Mio $ am 31.05.2026

Vermögen: 866 Mio $ am 31.05.2026
Vivek Ramaswamy ist ein Unternehmer und Geschäftsmann, der Roivant Sciences GmbH, Roivant Sciences, Inc., Campus Venture Network, Inc. und Roivant Sciences Ltd. gegründet hat und 10 verschiedene Unternehmen geleitet hat. Gegenwärtig ist Herr Ramaswamy geschäftsführender Vorsitzender von Roivant Sciences Ltd, geschäftsführender Vorsitzender der Roivant Sciences GmbH und geschäftsführender Vorsitzender bei Roivant Sciences, Inc. (beides Tochtergesellschaften von Roivant Sciences Ltd.) und Vorsitzender von Montes Archimedes Acquisition Corp. Herr Ramaswamy ist auch Mitglied des Vorstands von Sumitovant Biopharma, Inc. In seiner früheren Laufbahn war Herr Ramaswamy Vorsitzender bei Arbutus Biopharma Corp. und Vorsitzender bei Arbutus Biopharma, Inc. (eine Tochtergesellschaft der Arbutus Biopharma Corp.), Direktor bei Sio Gene Therapies, Inc. und Chief Executive Officer bei Axovant Sciences, Inc. (eine Tochtergesellschaft von Sio Gene Therapies, Inc.), Präsident von Campus Venture Network, Inc. und Investmentanalyst bei QVT Financial LP sowie Direktor bei Myovant Sciences Ltd. Er erwarb einen Abschluss an der Yale Law School und einen Bachelor-Abschluss am Harvard College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 25’534’970 ( 3.55% ) | 766 Mio $ | 31.05.2026 | |
Asset Entities, Inc.
Asset Entities, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as an asset management Bitcoin treasury company 42.1% | 28.05.2026 | 5’693’897 ( 42.1% ) | 101 Mio $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Vorstandsvorsitzender | 01.01.2021 |
| ROIVANT SCIENCES LTD. | Vorstandsvorsitzender | 01.01.2021 |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance Provides investment advice | Gründer | 01.05.2022 |
| MYOVANT SCIENCES LTD. | Vorsitzender | 07.11.2018 |
| ARBUTUS BIOPHARMA CORPORATION | Vorsitzender | 26.11.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Finance |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Campus Venture Network, Inc.
Campus Venture Network, Inc. Internet Software/ServicesTechnology Services Operates a website | Technology Services |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions | Health Technology |
Roivant Sciences Ltd.
Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Strive Enterprises, Inc.
Strive Enterprises, Inc. Financial ConglomeratesFinance Provides financial and wealth management services | Finance |
Yale Law School
Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Myovant Sciences Ltd.
Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Strive Asset Management LLC
Strive Asset Management LLC Investment ManagersFinance Provides investment advice | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen